-The Times of India Responding to a PIL filed by a retired Intelligence Bureau (IB) officer pointing at the complete absence of constitutional or statutory sanction for the agency, the Karnataka high court last week sought an explanation from the Centre, giving it time until March 30 to issue an executive order justifying IB's existence. The IB was formed on December 23, 1887, by the then British secretary of state as a...

-Reuters   Cheap generic drugs were meant to change the life of Nandakhu Nissar, whose mouth is swollen by a cancerous tumour. But the cashless and hungry 55-year-old sleeps on a pavement staring up at the windows of Mumbai's biggest cancer hospital.  "What is a generic drug?" shrugs Nissar, who has travelled over 1,500 kms (900 miles) from his home in the hope of treatment. "I have borrowed money from friends and relatives...

-The Telegraph The Economic Survey — prepared by Kaushik Basu, chief economic adviser to the finance ministry — has some gratuitous advice for politicians like Mamata Banerjee who announced earlier this week plans to amend state legislation that will require co-operative banks to take government permission before seizing mortgaged property while trying to foreclose loans given to defaulting farmers. “The state provides the laws and enforcement to enable people to sign contracts,”...

Often, municipal corporations carry out flawed projects which go against public interest and only suit vested interests. Use of RTI can help unearth such irregularities. Here’s a startling example... The Mula-Mutha rivers in Pune resemble stinking nallahs, yet the Pune Municipal Corporation (PMC) had a brainwave of implementing a river navigation project on a 25-odd km stretch from Ramwadi to Kharadi, envisioning boat rides as one of the activities to save...

In a landmark decision, India’s intellectual property office on Monday allowed Hyderabad-based Natco Pharma Ltd to make and sell a copycat version of German drug maker Bayer AG’s patented cancer treatment Nexavar. It’s the first time that an Indian company has been granted the so-called compulsory licence to market a generic version of a patented drug. The drug, patented by Bayer in India in 2008, is used in the treatment of...